New Edition,The 40-residue peptide (Aβ 1-40 ) is the most abundant Aβ isoform in the brain

The intricate world of neurodegenerative diseases often points to specific molecular players, and among the most significant in Alzheimer's disease (AD) are amyloid beta peptides, specifically Aβ(1-40) and Aβ(1-42). These peptides, which are fragments derived from the larger amyloid precursor protein (APP), are central to the formation of amyloid plaques, a hallmark pathology of AD. While both share common origins and participate in similar biological processes, their subtle structural differences lead to distinct behaviors and implications for disease progression.

Aβ peptides are generally defined as peptides of 36–43 amino acids. The two most studied and prevalent forms are Aβ(1-40), a 40-residue peptide, and Aβ(1-42), a 42-residue peptide. The primary distinction lies in their length: Aβ(1-42) has two extra residues at the C-terminus compared to Aβ(1-40). This seemingly minor difference in amino acid sequence significantly impacts their propensity to aggregate and their overall toxicity.

Aggregation Propensity and Toxicity

Research has consistently shown that Aβ(1-42) exhibits a markedly increased propensity to form amyloid fibrils in vitro compared to Aβ(1-40). This heightened aggregation tendency is believed to be a key factor in its greater contribution to AD pathogenesis. While both amyloid peptides Aβ(1-40) and Aβ(1-42) can form aggregates, the aggregation states of amyloid beta peptides for Aβ(1-40) to Aβ(1-42) and other related peptides are a subject of ongoing investigation. Studies employing techniques like small-angle neutron scattering (SANS) have been used to investigate these varying aggregation patterns.

The increased toxicity of Aβ(1-42) is also well-documented. Soluble Aβ(1-42) has been shown to inhibit long-term potentiation (LTP), a cellular mechanism crucial for learning and memory, and is believed to be involved in the pathogenesis of AD that precedes cellular death and cognitive decline. In contrast, Aβ(1-40) has been shown to inhibit Aβ(1-42) induced toxicity; pre-mixing Aβ(1-40) with Aβ(1-42) has been observed to significantly reduce the detrimental effects of Aβ(1-42) on synapses, potentially increasing both synaptic vesicle recycling and function.

Abundance and Distribution

Despite the greater pathogenicity of Aβ(1-42), Aβ(1-40) is generally found in much higher concentrations in biological fluids. For instance, Aβ(1-40) is the most abundant amyloid peptide in CSF (cerebrospinal fluid), accounting for approximately 90% of the total Aβ peptide population. Aβ(1-42) accounts for only about 10% of the total Aβ peptide population in CSF. Similarly, the 40-residue peptide (Aβ 1-40) is the most abundant Aβ isoform in the brain. This difference in abundance is also reflected in plasma concentrations, with studies showing higher plasma levels of Aβ(1-42) and Aβ(1-40) at specific time points post-sampling.

Biomarker Potential

The differing concentrations and aggregation behaviors of these peptides have led to their investigation as potential biomarkers for Alzheimer's disease. The Aβ(1-42)/Aβ(1-40) ratio in both CSF and plasma has garnered significant attention. A reduced Aβ(1-42)/Aβ(1-40) peptide ratio in blood plasma is considered a peripheral biomarker of cerebral amyloid pathology observed in AD. Specifically, the free plasma Aβ(1-42)/Aβ(1-40) ratio has been associated with an increased risk of conversion from mild cognitive impairment (MCI) to dementia within three years, with performance comparable to other established diagnostic markers. While Aβ(1-40) is the most abundant Aβ peptide isoform in the CSF, the Aβ(1-42)/Aβ(1-40) ratio is suggested to provide a more comprehensive picture of the underlying pathology than Aβ(1-42) levels alone.

Structural and Conformational Aspects

While the primary sequence difference is minimal, it has profound effects on the three-dimensional structures these peptides adopt. Solution NMR studies of the Aβ(1-40) and Aβ(1-42) have revealed distinct conformational preferences. NMR-guided simulations of Aβ peptides 1-40 (Aβ40) and 1-42 (Aβ42) also suggest very different conformational states, particularly regarding the C-terminus.